84 related articles for article (PubMed ID: 22126015)
1. Interleukin-1beta-induced iNOS expression in human lung carcinoma A549 cells: involvement of STAT and MAPK pathways.
Ravichandran K; Tyagi A; Deep G; Agarwal C; Agarwal R
Indian J Exp Biol; 2011 Nov; 49(11):840-7. PubMed ID: 22126015
[TBL] [Abstract][Full Text] [Related]
2. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
[TBL] [Abstract][Full Text] [Related]
3. β-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells.
Ji DB; Xu B; Liu JT; Ran FX; Cui JR
Mol Carcinog; 2011 Dec; 50(12):945-60. PubMed ID: 21400616
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.
Chittezhath M; Deep G; Singh RP; Agarwal C; Agarwal R
Mol Cancer Ther; 2008 Jul; 7(7):1817-26. PubMed ID: 18644994
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
6. HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride.
Tsoyi K; Kim HJ; Shin JS; Kim DH; Cho HJ; Lee SS; Ahn SK; Yun-Choi HS; Lee JH; Seo HG; Chang KC
Cell Signal; 2008 Oct; 20(10):1839-47. PubMed ID: 18634870
[TBL] [Abstract][Full Text] [Related]
7. Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway.
Kou X; Qi S; Dai W; Luo L; Yin Z
Int Immunopharmacol; 2011 Aug; 11(8):1095-102. PubMed ID: 21426947
[TBL] [Abstract][Full Text] [Related]
8. Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway.
Senggunprai L; Kukongviriyapan V; Prawan A; Kukongviriyapan U
Phytother Res; 2014 Jun; 28(6):841-8. PubMed ID: 24038588
[TBL] [Abstract][Full Text] [Related]
9. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAW264.7 mouse macrophage cells in vitro through treatment with recombinant ricin toxin-binding subunit B: involvement of protein tyrosine, NF-κB and JAK-STAT kinase signaling pathways.
Xu N; Yuan H; Liu W; Li S; Liu Y; Wan J; Li X; Zhang R; Chang Y
Int J Mol Med; 2013 Sep; 32(3):729-35. PubMed ID: 23820591
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells.
Ziesché E; Bachmann M; Kleinert H; Pfeilschifter J; Mühl H
J Biol Chem; 2007 Jun; 282(22):16006-15. PubMed ID: 17438334
[TBL] [Abstract][Full Text] [Related]
12. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
[TBL] [Abstract][Full Text] [Related]
13. Leptin enhances human beta-defensin-2 production in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2008 Oct; 149(10):5189-98. PubMed ID: 18556347
[TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid and luteolin synergistically inhibit the proliferation of interleukin-1β-induced fibroblast-like synoviocytes through regulating the activation of NF-κB and JAK/STAT-signaling pathways.
Lou L; Liu Y; Zhou J; Wei Y; Deng J; Dong B; Chai L
Immunopharmacol Immunotoxicol; 2015; 37(6):499-507. PubMed ID: 26471424
[TBL] [Abstract][Full Text] [Related]
15. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
16. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin 1β-stimulated interleukin-6 production by cranberry components in human gingival epithelial cells: effects on nuclear factor κB and activator protein 1 activation pathways.
Tipton DA; Carter TB; Dabbous MKh
J Periodontal Res; 2014 Aug; 49(4):437-47. PubMed ID: 23952046
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
Lim H; Kim HP
Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
